PT1682122E - Combinação de antagonistas at1, amiloride ou triantereno, e um diurético - Google Patents
Combinação de antagonistas at1, amiloride ou triantereno, e um diurético Download PDFInfo
- Publication number
- PT1682122E PT1682122E PT04797529T PT04797529T PT1682122E PT 1682122 E PT1682122 E PT 1682122E PT 04797529 T PT04797529 T PT 04797529T PT 04797529 T PT04797529 T PT 04797529T PT 1682122 E PT1682122 E PT 1682122E
- Authority
- PT
- Portugal
- Prior art keywords
- diuretic
- amiloride
- triamterine
- valsartan
- combinations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0325605.4A GB0325605D0 (en) | 2003-11-03 | 2003-11-03 | Combination of organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1682122E true PT1682122E (pt) | 2008-06-18 |
Family
ID=29725841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT04797529T PT1682122E (pt) | 2003-11-03 | 2004-11-02 | Combinação de antagonistas at1, amiloride ou triantereno, e um diurético |
Country Status (16)
Country | Link |
---|---|
US (2) | US20070072848A1 (pt) |
EP (1) | EP1682122B9 (pt) |
JP (1) | JP2007509900A (pt) |
KR (1) | KR20060097025A (pt) |
CN (1) | CN1878548A (pt) |
AT (1) | ATE389399T1 (pt) |
AU (1) | AU2004290505B2 (pt) |
BR (1) | BRPI0416154A (pt) |
CA (1) | CA2544230A1 (pt) |
DE (1) | DE602004012593T2 (pt) |
ES (1) | ES2303958T3 (pt) |
GB (1) | GB0325605D0 (pt) |
PL (1) | PL1682122T3 (pt) |
PT (1) | PT1682122E (pt) |
RU (1) | RU2006119329A (pt) |
WO (1) | WO2005049013A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090062309A1 (en) * | 2007-08-28 | 2009-03-05 | Antonio Delgado-Almeida | Therapeutic compositions for the treatment of cardiovascular diseases and methods for use therefor |
EP2704706A1 (en) | 2011-05-06 | 2014-03-12 | Artskin D.O.O. | Composition comprising angiotensin ii receptor antagonist and antioxidant for maintaining and/or improving skin properties |
CN102793703A (zh) * | 2011-05-25 | 2012-11-28 | 苏州洪瑞医药科技有限公司 | 一种盐酸阿米洛利和环戊噻嗪的药物组合物及其制备方法 |
CN109475552B (zh) * | 2016-08-09 | 2022-04-05 | 上海药苑生物科技有限公司 | 用于食欲控制和体重管理的方法和组合物 |
CN109364248B (zh) * | 2018-10-16 | 2021-05-18 | 哈尔滨医科大学 | ENaC及其抑制剂在预防、缓解和/或治疗动脉粥样硬化中的应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4898729A (en) * | 1983-12-09 | 1990-02-06 | Euroceltique, S.A. | Treatment of hypertension, compounds and compositions for antihypertension and diuresis |
GB9613470D0 (en) * | 1996-06-27 | 1996-08-28 | Ciba Geigy Ag | Small solid oral dosage form |
AU8026200A (en) * | 1999-10-19 | 2001-04-30 | Board Of Regents, The University Of Texas System | Treatment of heart disease with cox-2 inhibitors |
US8168616B1 (en) * | 2000-11-17 | 2012-05-01 | Novartis Ag | Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension |
WO2002043807A2 (en) * | 2000-12-01 | 2002-06-06 | Novartis Ag | Combinations of an angiotensin receptor antagonist and an anti-hypertensive drug or a statin, for the treatment of sexual dysfunction |
EG24716A (en) * | 2002-05-17 | 2010-06-07 | Novartis Ag | Combination of organic compounds |
-
2003
- 2003-11-03 GB GBGB0325605.4A patent/GB0325605D0/en not_active Ceased
-
2004
- 2004-02-11 US US10/577,370 patent/US20070072848A1/en not_active Abandoned
- 2004-11-02 KR KR1020067008517A patent/KR20060097025A/ko not_active Application Discontinuation
- 2004-11-02 RU RU2006119329/15A patent/RU2006119329A/ru not_active Application Discontinuation
- 2004-11-02 CA CA002544230A patent/CA2544230A1/en not_active Abandoned
- 2004-11-02 AU AU2004290505A patent/AU2004290505B2/en not_active Ceased
- 2004-11-02 PT PT04797529T patent/PT1682122E/pt unknown
- 2004-11-02 ES ES04797529T patent/ES2303958T3/es active Active
- 2004-11-02 PL PL04797529T patent/PL1682122T3/pl unknown
- 2004-11-02 WO PCT/EP2004/012386 patent/WO2005049013A1/en active IP Right Grant
- 2004-11-02 JP JP2006537238A patent/JP2007509900A/ja active Pending
- 2004-11-02 AT AT04797529T patent/ATE389399T1/de not_active IP Right Cessation
- 2004-11-02 BR BRPI0416154-8A patent/BRPI0416154A/pt not_active IP Right Cessation
- 2004-11-02 DE DE602004012593T patent/DE602004012593T2/de not_active Revoked
- 2004-11-02 CN CNA2004800329189A patent/CN1878548A/zh active Pending
- 2004-11-02 EP EP04797529A patent/EP1682122B9/en not_active Revoked
-
2008
- 2008-09-26 US US12/286,039 patent/US20090036432A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20090036432A1 (en) | 2009-02-05 |
WO2005049013A1 (en) | 2005-06-02 |
BRPI0416154A (pt) | 2007-01-09 |
ES2303958T3 (es) | 2008-09-01 |
AU2004290505A1 (en) | 2005-06-02 |
ATE389399T1 (de) | 2008-04-15 |
JP2007509900A (ja) | 2007-04-19 |
DE602004012593T2 (de) | 2009-04-23 |
RU2006119329A (ru) | 2007-12-27 |
PL1682122T3 (pl) | 2008-09-30 |
DE602004012593D1 (de) | 2008-04-30 |
EP1682122B1 (en) | 2008-03-19 |
EP1682122B9 (en) | 2009-04-08 |
AU2004290505B2 (en) | 2007-09-20 |
CA2544230A1 (en) | 2005-06-02 |
KR20060097025A (ko) | 2006-09-13 |
GB0325605D0 (en) | 2003-12-10 |
US20070072848A1 (en) | 2007-03-29 |
CN1878548A (zh) | 2006-12-13 |
EP1682122A1 (en) | 2006-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001076574A3 (en) | Novel medical use of aldosterone synthase inhibitors alone or in combination with at1-receptor antagonists | |
WO2007048027A3 (en) | Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent | |
WO2001076573A3 (en) | Combination of at least two compounds selected from an at1-receptor antagonist or an ace inhibitor or a hmg-co-a reductase inhibitor groups | |
EP2415760A3 (en) | CCR-9 antagonists | |
WO2004096798A3 (fr) | Derives de 2-acylamino-4-phenylthiazole, leur preparation et leur application en therapeutique | |
UA96449C2 (en) | Stable laquinimod preparations | |
TW200621737A (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof | |
CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
WO2006056696A3 (fr) | 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation | |
BR0317555A (pt) | Composições farmacêuticas de sertaconazol para uso vaginal | |
WO2006072070A3 (en) | Pharmaceutical formulations of gallium salts | |
IT1302682B1 (it) | Composizioni farmaceutiche orali contenenti buprenorfina | |
EP1262196A3 (en) | Combination of a monoamine reuptake inhibitor and an opioid antagonist for use in alcoholism and alcohol dependence | |
WO2005032490A3 (en) | Cyclic diamines and derivatives as factor xa inhibitors | |
WO2002015933A3 (en) | Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser | |
ITRM20030363A0 (it) | Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse. | |
WO2005056577A3 (en) | Peptide inhibitors of hiv | |
PL1682122T3 (pl) | Kombinacja walsartanu, amiloridu lub triamterenu i diuretyka | |
WO2004098577A3 (en) | Dosage form containing (s)-pantoprazole as active ingredient | |
TW200503783A (en) | Oral pharmaceutical preparation for proton pump antagonists | |
WO2007005763A3 (en) | Combination of a renin inhibitor and an insulin secretion enhancer or an insulin sensitizer | |
MY139409A (en) | Benzoxazine and quinoxaline and uses | |
AU2003281468A1 (en) | P-glycoprotein inhibitor comprising octilonium bromide as an effective ingredient | |
WO2004043366A3 (en) | Sulfonamides | |
WO2004043368A3 (en) | Sulfonamides |